Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (21-30 of 299) with videos related to

Pageof 30
Sort By:
American Journal of Hematology|November 26, 2013
Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Oncology (Williston Park, N.Y.)|July 31, 2010
Understanding evaluation and management of primary cutaneous and systemic ALCLJulie M Vose
Hematological Oncology|February 1, 2006
Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approachJulie M Vose
Hematology/Oncology Clinics of North America|October 29, 2008
Peripheral T-cell non-Hodgkin's lymphomaJulie M Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Relapsed diffuse large B-cell lymphoma: clinical utility of cell of originJulie M Vose
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 21, 2013
Molecular pathogenesis in non-Hodgkin lymphoma: implications for therapyJulie M Vose
Oncology (Williston Park, N.Y.)|September 23, 2020
Delay in Cancer Screening and Diagnosis During the COVID-19 Pandemic: What Is the Cost?Julie M Vose
The Lancet. Haematology|September 24, 2020
Mantle cell lymphoma: minimal residual disease outcomesJulie M Vose
Oncology (Williston Park, N.Y.)|July 17, 2020
COVID-19 Pandemic and Its Effects on Cancer Care, Both Good and BadJulie M Vose
JCO Clinical Cancer Informatics|January 19, 2019
Learning From Our PatientsJulie M Vose, Daniel Hayes
Pageof 30

Showing results (21-30 of 299) with videos related to

Sort By:
Pageof 30
American Journal of Hematology|November 26, 2013
Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Oncology (Williston Park, N.Y.)|July 31, 2010
Understanding evaluation and management of primary cutaneous and systemic ALCLJulie M Vose
Hematological Oncology|February 1, 2006
Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approachJulie M Vose
Hematology/Oncology Clinics of North America|October 29, 2008
Peripheral T-cell non-Hodgkin's lymphomaJulie M Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Relapsed diffuse large B-cell lymphoma: clinical utility of cell of originJulie M Vose
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 21, 2013
Molecular pathogenesis in non-Hodgkin lymphoma: implications for therapyJulie M Vose
Oncology (Williston Park, N.Y.)|September 23, 2020
Delay in Cancer Screening and Diagnosis During the COVID-19 Pandemic: What Is the Cost?Julie M Vose
The Lancet. Haematology|September 24, 2020
Mantle cell lymphoma: minimal residual disease outcomesJulie M Vose
Oncology (Williston Park, N.Y.)|July 17, 2020
COVID-19 Pandemic and Its Effects on Cancer Care, Both Good and BadJulie M Vose
JCO Clinical Cancer Informatics|January 19, 2019
Learning From Our PatientsJulie M Vose, Daniel Hayes
Pageof 30